Pfizer Stock Surges as Its Oral Weight-Loss Drug Challenges Ozempic

Here's what traders need to know.

A Triple Shot of Triple-Nets Deep in the Heart of Value Land

Of these interesting candidates, two of them are new, and one a repeat offender.

Meta, Fined by the EU, Should Be Okay for Now: But When Do Traders Cut Bait?

If this fine is paid in full with no appeal and or no settlement, that would leave a nasty mark.

Here's Which Way the Market Is Trending and How We'd Play It

Our latest look at the charts and indicators and what they reveal.

As G7 Blasts China's 'Coercion,' Micron Falls as First Victim

The Hiroshima summit issued a surprisingly strident criticism of China's trade tactics and 'economic coercion,' at virtually the same time that China declared that Micron had failed a cybersecurity review.

3 Issues Will Dominate the Market Action This Week

Debt, markets, inflation and growth are what to watch.

Debt Ceiling, Marketplace, Fed Talk, More Earnings, Busy Week Ahead

The focus this week will once again be on political posturing and political theater and its impact on the US and global economies as well as on financial markets.

Approach Poor Markets Like a Navy SEAL: 'Embrace the Suck'

Bad market action is a boon to opportunistic traders with the right mindset. Here's how to love the misery and use it to your advantage.

Nike Just Can't Do It

The stock has broken support signaling further losses may lie ahead.

2 Small-Cap Stocks That Are Making Significant Progress

For now they're to be considered speculative.